A recombinant adenovirus expressing wild-type bax induces apoptosis in prostate cancer cells independently of their Bcl-2 status and androgen sensitivity

Tsuyoshi Honda, Shunsuke Kagawa, Kevin B. Spurgers, Bjorn T. Gjertsen, Jack A. Roth, Bingliang Fang, Stephanie L. Lowe, James S. Norris, Raymond E. Meyn, Timothy J. McDonnell

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Using a binary co-transfection strategy of Ad/GT Bax and Ad/PGK-GV16, we have succeeded in inducing overexpression of Bax protein in three prostate cell lines (androgen-insensitive DU145 and PC3, and androgen-sensitive LNCaP). The expression of Bax protein by this system was sufficient to induce all three prostate lines to undergo apoptosis. The fact that DU145 cells which have a p53 mutation and are deficient in Bax, responded to this treatment, suggests that this effect is independent of these pathways. Initiation of the cleavage of Caspase-3 (CPP32/Yama/apopain) and PARP (poly (ADP-ribose) polymerase) by the introduction of Bax were confirmed by western blot analysis. Bcl-2 expression is relevant in the progression of prostate cancer and contributes to an androgen, apoptotic-resistant phenotype in the advanced stages. We examined stable Bcl-2 overexpressing DU145, PC3 and LNCaP cell lines as models of advanced prostate cancer. The adenoviral co-transfection system induced Bax protein expression and apoptosis even in these Bcl-2 transfected cell lines. Taken together, our results suggest that this Bax expression system might represent a useful gene therapy strategy when applied to the treatment of prostate cancer and its efficacy would be independent of the Bcl-2 status and androgen sensitivity of these cancers.

Original languageEnglish
Pages (from-to)163-167
Number of pages5
JournalCancer Biology and Therapy
Volume1
Issue number2
Publication statusPublished - Mar 2002
Externally publishedYes

Fingerprint

Adenoviridae
bcl-2-Associated X Protein
Androgens
Prostatic Neoplasms
Apoptosis
Cell Line
Caspase 3
Transfection
Prostate
Poly(ADP-ribose) Polymerases
Genetic Therapy
Western Blotting
Phenotype
Mutation
Therapeutics
Neoplasms

Keywords

  • Adenoviral
  • Androgen
  • Apoptosis
  • Bax
  • Bcl-2
  • Caspase
  • Prostate

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Molecular Medicine
  • Pharmacology

Cite this

A recombinant adenovirus expressing wild-type bax induces apoptosis in prostate cancer cells independently of their Bcl-2 status and androgen sensitivity. / Honda, Tsuyoshi; Kagawa, Shunsuke; Spurgers, Kevin B.; Gjertsen, Bjorn T.; Roth, Jack A.; Fang, Bingliang; Lowe, Stephanie L.; Norris, James S.; Meyn, Raymond E.; McDonnell, Timothy J.

In: Cancer Biology and Therapy, Vol. 1, No. 2, 03.2002, p. 163-167.

Research output: Contribution to journalArticle

Honda, T, Kagawa, S, Spurgers, KB, Gjertsen, BT, Roth, JA, Fang, B, Lowe, SL, Norris, JS, Meyn, RE & McDonnell, TJ 2002, 'A recombinant adenovirus expressing wild-type bax induces apoptosis in prostate cancer cells independently of their Bcl-2 status and androgen sensitivity', Cancer Biology and Therapy, vol. 1, no. 2, pp. 163-167.
Honda, Tsuyoshi ; Kagawa, Shunsuke ; Spurgers, Kevin B. ; Gjertsen, Bjorn T. ; Roth, Jack A. ; Fang, Bingliang ; Lowe, Stephanie L. ; Norris, James S. ; Meyn, Raymond E. ; McDonnell, Timothy J. / A recombinant adenovirus expressing wild-type bax induces apoptosis in prostate cancer cells independently of their Bcl-2 status and androgen sensitivity. In: Cancer Biology and Therapy. 2002 ; Vol. 1, No. 2. pp. 163-167.
@article{fc4b6d72a65242d5b0414089e3c636f0,
title = "A recombinant adenovirus expressing wild-type bax induces apoptosis in prostate cancer cells independently of their Bcl-2 status and androgen sensitivity",
abstract = "Using a binary co-transfection strategy of Ad/GT Bax and Ad/PGK-GV16, we have succeeded in inducing overexpression of Bax protein in three prostate cell lines (androgen-insensitive DU145 and PC3, and androgen-sensitive LNCaP). The expression of Bax protein by this system was sufficient to induce all three prostate lines to undergo apoptosis. The fact that DU145 cells which have a p53 mutation and are deficient in Bax, responded to this treatment, suggests that this effect is independent of these pathways. Initiation of the cleavage of Caspase-3 (CPP32/Yama/apopain) and PARP (poly (ADP-ribose) polymerase) by the introduction of Bax were confirmed by western blot analysis. Bcl-2 expression is relevant in the progression of prostate cancer and contributes to an androgen, apoptotic-resistant phenotype in the advanced stages. We examined stable Bcl-2 overexpressing DU145, PC3 and LNCaP cell lines as models of advanced prostate cancer. The adenoviral co-transfection system induced Bax protein expression and apoptosis even in these Bcl-2 transfected cell lines. Taken together, our results suggest that this Bax expression system might represent a useful gene therapy strategy when applied to the treatment of prostate cancer and its efficacy would be independent of the Bcl-2 status and androgen sensitivity of these cancers.",
keywords = "Adenoviral, Androgen, Apoptosis, Bax, Bcl-2, Caspase, Prostate",
author = "Tsuyoshi Honda and Shunsuke Kagawa and Spurgers, {Kevin B.} and Gjertsen, {Bjorn T.} and Roth, {Jack A.} and Bingliang Fang and Lowe, {Stephanie L.} and Norris, {James S.} and Meyn, {Raymond E.} and McDonnell, {Timothy J.}",
year = "2002",
month = "3",
language = "English",
volume = "1",
pages = "163--167",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "2",

}

TY - JOUR

T1 - A recombinant adenovirus expressing wild-type bax induces apoptosis in prostate cancer cells independently of their Bcl-2 status and androgen sensitivity

AU - Honda, Tsuyoshi

AU - Kagawa, Shunsuke

AU - Spurgers, Kevin B.

AU - Gjertsen, Bjorn T.

AU - Roth, Jack A.

AU - Fang, Bingliang

AU - Lowe, Stephanie L.

AU - Norris, James S.

AU - Meyn, Raymond E.

AU - McDonnell, Timothy J.

PY - 2002/3

Y1 - 2002/3

N2 - Using a binary co-transfection strategy of Ad/GT Bax and Ad/PGK-GV16, we have succeeded in inducing overexpression of Bax protein in three prostate cell lines (androgen-insensitive DU145 and PC3, and androgen-sensitive LNCaP). The expression of Bax protein by this system was sufficient to induce all three prostate lines to undergo apoptosis. The fact that DU145 cells which have a p53 mutation and are deficient in Bax, responded to this treatment, suggests that this effect is independent of these pathways. Initiation of the cleavage of Caspase-3 (CPP32/Yama/apopain) and PARP (poly (ADP-ribose) polymerase) by the introduction of Bax were confirmed by western blot analysis. Bcl-2 expression is relevant in the progression of prostate cancer and contributes to an androgen, apoptotic-resistant phenotype in the advanced stages. We examined stable Bcl-2 overexpressing DU145, PC3 and LNCaP cell lines as models of advanced prostate cancer. The adenoviral co-transfection system induced Bax protein expression and apoptosis even in these Bcl-2 transfected cell lines. Taken together, our results suggest that this Bax expression system might represent a useful gene therapy strategy when applied to the treatment of prostate cancer and its efficacy would be independent of the Bcl-2 status and androgen sensitivity of these cancers.

AB - Using a binary co-transfection strategy of Ad/GT Bax and Ad/PGK-GV16, we have succeeded in inducing overexpression of Bax protein in three prostate cell lines (androgen-insensitive DU145 and PC3, and androgen-sensitive LNCaP). The expression of Bax protein by this system was sufficient to induce all three prostate lines to undergo apoptosis. The fact that DU145 cells which have a p53 mutation and are deficient in Bax, responded to this treatment, suggests that this effect is independent of these pathways. Initiation of the cleavage of Caspase-3 (CPP32/Yama/apopain) and PARP (poly (ADP-ribose) polymerase) by the introduction of Bax were confirmed by western blot analysis. Bcl-2 expression is relevant in the progression of prostate cancer and contributes to an androgen, apoptotic-resistant phenotype in the advanced stages. We examined stable Bcl-2 overexpressing DU145, PC3 and LNCaP cell lines as models of advanced prostate cancer. The adenoviral co-transfection system induced Bax protein expression and apoptosis even in these Bcl-2 transfected cell lines. Taken together, our results suggest that this Bax expression system might represent a useful gene therapy strategy when applied to the treatment of prostate cancer and its efficacy would be independent of the Bcl-2 status and androgen sensitivity of these cancers.

KW - Adenoviral

KW - Androgen

KW - Apoptosis

KW - Bax

KW - Bcl-2

KW - Caspase

KW - Prostate

UR - http://www.scopus.com/inward/record.url?scp=0036491256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036491256&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 163

EP - 167

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 2

ER -